Inside NuVasive’s Upcoming Second Quarter Earnings Release

NuVasive, Inc. (NASDAQ:NUVA) will unveil its latest earnings on Monday, July 25, 2011. NuVasive, Inc. is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

NuVasive, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 18 cents per share, a decline of 25% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from 16 cents. For the year, analysts are projecting profit of 76 cents per share, a decline of 17.4% from last year.

Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 3 cents, reporting net income of 10 cents per share against a mean estimate of profit of 7 cents per share.

Savvy Investing Tip: Our CHEAT SHEET investing framework recommends only stocks with two straight quarters of earnings growth. Learn More >>

Wall St. Revenue Expectations: On average, analysts predict $132 million in revenue this quarter, a rise of 10.4% from the year ago quarter. Analysts are forecasting total revenue of $535 million for the year, a rise of 11.9% from last year’s revenue of $478.2 million.

Analyst Ratings: Analysts seem relatively indifferent about NuVasive with 13 of 23 analysts surveyed maintaining a hold rating.

Key Stats:

The company has enjoyed double-digit year-over-year percentage revenue growth for the past four quarters. Over that span, the company has averaged growth of 24.2%, with the biggest boost coming in the second quarter of the last fiscal year when revenue rose 35.2% from the year earlier quarter.

The company has now seen net income rise in three straight quarters. In the first quarter, net income rose more than twofold while it rose sharply in the fourth quarter of the last fiscal year and 68.7% in the third quarter of the last fiscal year.

Competitors to Watch: Alphatec Holdings, Inc. (NASDAQ:ATEC), Stryker Corporation (NYSE:SYK), Zimmer Holdings, Inc. (NYSE:ZMH), TranS1 Inc. (NASDAQ:TSON), Orthofix International NV (NASDAQ:OFIX), Medtronic, Inc. (NYSE:MDT), Exactech, Inc. (NASDAQ:EXAC), Wright Medical Group, Inc. (NASDAQ:WMGI), Orthovita, Inc. (NASDAQ:VITA), and RTI Biologics Inc. (NASDAQ:RTIX).

Stock Price Performance: During April 21, 2011 to July 19, 2011, the stock price had risen $4.69 (16.9%) from $27.83 to $32.52. The stock price saw one of its best stretches over the last year between April 8, 2011 and April 18, 2011 when shares rose for seven-straight days, rising 7.3% (+$1.87) over that span. It saw one of its worst periods between July 7, 2011 and July 18, 2011 when shares fell for eight-straight days, falling 10% (-$3.45) over that span. Shares are up $6.87 (+26.8%) year to date.

(Source: Xignite Financials)

Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!